Researchers survey a broadening landscape of studies showing what’s known, and what remains to be found, about the therapeutic potential of noninvasive sensory, electrical, or magnetic stimulation of gamma brain rhythms.
Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Postdoc researcher recognized for leukemia management innovation.
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
New approach could kill tumor cells in the brain more effectively and avoid side effects.
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.
Measuring enzyme levels in patients may reveal healthy cells’ ability to survive chemotherapy.